Welcome to our dedicated page for Calumet SEC filings (Ticker: CLMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page compiles U.S. SEC filings for Calumet, Inc. (NASDAQ: CLMT), a petroleum refineries industry company that manufactures, formulates and markets specialty branded products and renewable fuels. Through these filings, investors can review Calumet’s regulatory disclosures on operations, financing activities, internal controls and segment performance across Specialty Products and Solutions, Montana/Renewables, Performance Brands and Corporate.
Current reports on Form 8-K are a central source of Calumet information. The company uses Item 2.02 filings to furnish results of operations and financial condition for specific quarters, referencing press releases that contain detailed financial data. These 8-Ks allow readers to see how Calumet reports quarterly performance, including metrics such as net income (loss) and non-GAAP measures like Adjusted EBITDA and Adjusted EBITDA with Tax Attributes, which the company explains in its disclosures.
Calumet has also filed 8-Ks under Item 4.02 describing non-reliance on previously issued financial statements. In one such filing, the Audit Committee concluded that unaudited interim consolidated financial statements for certain 2025 periods required restatement due to an error in the unaudited condensed consolidated statements of cash flows. The company explained that the error involved misclassification between operating and financing cash flows, did not affect revenue, net income (loss) or cash and cash equivalents, and was associated with a material weakness in internal control over financial reporting. The filing outlines planned restatements and discussions with the independent registered public accounting firm.
Other 8-K filings detail material definitive agreements and related transactions. For example, Calumet reported a sale and leaseback transaction for property comprising the Shreveport refinery fuels terminal, truck rack and related piping and equipment, documented under a Master Lease Agreement and property schedule with Stonebriar Commercial Finance LLC. The filing describes lease terms, rental payments, an option to repurchase the leased assets, application of proceeds to prior obligations, and related amendments to the company’s credit agreement and monetization master agreement.
Calumet’s filings also reference its capital structure, including various series of senior notes such as 11.00% Senior Notes due 2026, 8.125% Senior Notes due 2027, 9.75% Senior Notes due 2028 (including a mirror issuance), and 9.25% Senior Secured First Lien Notes due 2029. Definitions of "Consolidated Cash Flow" and "Consolidated EBITDA" used in these instruments are linked to the company’s non-GAAP measures, and the filings explain how these metrics are reported to noteholders and lenders.
On Stock Titan, Calumet’s SEC filings are updated from EDGAR and presented with AI-powered summaries. AI analysis highlights key terms in 10-K and 10-Q reports, explains complex sections such as non-GAAP reconciliations and covenant definitions, and surfaces important items from 8-Ks, including restatement notices, internal control disclosures and material transactions. Users can also review Form 4 and other ownership filings to track insider transactions, alongside proxy and other statements that address governance and compensation when available.
By combining real-time access to Calumet’s SEC submissions with AI-generated explanations, this page helps readers understand how the company reports its specialty products and renewable fuels operations, manages its capital structure and addresses financial reporting and control matters in its official filings.
Calumet, Inc. reported that board member Jennifer G. Straumins has decided not to stand for re-election and will retire from the Board at the end of her current term, which expires at the Company’s 2026 Annual Meeting of Stockholders.
The Company stated that her decision is not due to any disagreement with its operations, policies, or practices. Calumet issued a press release with additional background on her long association with the business and noted that the Board, through its Nominating and Governance Committee, will continue evaluating Board composition and skills to align with the Company’s strategy and governance practices.
Calumet, Inc. has completed a private placement of $150 million in additional 9.75% Senior Notes due 2031 through its subsidiaries Calumet Specialty Products Partners, L.P. and Calumet Finance Corp. The notes were sold at 105% of par, generating net proceeds of approximately $154.9 million.
The company intends to use these proceeds to repay borrowings outstanding under its revolving credit facility, effectively terming out a portion of its short-term debt into longer-dated senior notes. These Additional Notes form a single series with the existing $405 million of 9.75% Senior Notes due 2031, sharing the same terms other than initial offering price.
Calumet, Inc. announced that its subsidiaries agreed to sell $150 million aggregate principal amount of 9.75% Senior Notes due 2031 in a private offering under Rule 144A and Regulation S. The notes will be issued at 105% of par, generating approximately $154.9 million in net proceeds, which Calumet plans to use to repay borrowings under its revolving credit facility.
The new notes are an additional issuance to the existing $405 million of 9.75% Senior Notes due 2031, forming a single series with the same terms other than initial offering price. Calumet also executed a Tenth Amendment to its Third Amended and Restated Credit Agreement to permit this new indebtedness.
Calumet, Inc. has announced that its subsidiaries intend to privately issue $150 million of 9.75% Senior Notes due 2031 as a tack-on to existing notes. The new notes will form a single series with $405 million of the same 9.75% Senior Notes issued on January 12, 2026.
The company plans to use the net proceeds to repay borrowings under its revolving credit facility, effectively refinancing debt. The offering will be made to eligible purchasers under Rule 144A and Regulation S and the notes will not be registered under the Securities Act.
Calumet, Inc. has announced that its subsidiaries intend to privately issue $150 million of 9.75% Senior Notes due 2031 as a tack-on to existing notes. The new notes will form a single series with $405 million of the same 9.75% Senior Notes issued on January 12, 2026.
The company plans to use the net proceeds to repay borrowings under its revolving credit facility, effectively refinancing debt. The offering will be made to eligible purchasers under Rule 144A and Regulation S and the notes will not be registered under the Securities Act.
Calumet, Inc. EVP – Specialties Scott Obermeier exercised 24,090 restricted stock units into common shares on March 9, 2026. Each unit was economically equivalent to one share of common stock. To satisfy tax withholding liabilities, he surrendered 10,584 common shares to the company rather than selling them in the market. After these compensation-related transactions, he directly owned 237,656 shares of Calumet common stock.
Calumet, Inc. (CLMT) senior vice president and general counsel Gregory J. Morical exercised vested restricted stock units and settled related taxes in shares. On March 9, 2026, he converted 15,348 Restricted Stock Units into 15,348 shares of common stock at an exercise price of $0.00 per share.
Footnotes state that each Restricted Stock Unit equaled one share of common stock and that 100% of the units vested on February 21, 2026. To cover tax withholding obligations under Rule 16b-3, he surrendered 6,952 shares of common stock back to the issuer. After these transactions, he directly owned 47,811 shares of Calumet, Inc. common stock. This pattern reflects routine equity compensation vesting, with part of the award used to satisfy taxes rather than an open-market sale.
Calumet, Inc. director Stephen P. Mawer exercised 27,806 Restricted Stock Units into an equal number of common shares on March 9, 2026. All RSUs had fully vested on February 21, 2026. To cover tax withholding obligations, he surrendered 12,589 common shares back to the company. After these compensation-related transactions, he directly holds 303,310 shares of Calumet common stock.
Calumet, Inc. EVP Bruce A. Fleming exercised 20,621 Restricted Stock Units on March 9, 2026, receiving the same number of shares of common stock at a stated price of $0.00 per share. Each unit was economically equivalent to one share of common stock, and the units had vested 100% on February 21, 2026.
To cover tax withholding obligations upon delivery of the stock, Fleming surrendered 8,156 shares, a disposition treated as payment of tax liabilities rather than an open-market sale. After these transactions, he held 549,963 shares of Calumet common stock directly, reflecting a net increase in his equity position.
Calumet, Inc. chief executive officer Louis Todd Borgmann exercised 49,974 Restricted Stock Units into common stock on March 9, 2026. Each Restricted Stock Unit was the economic equivalent of one share of Calumet common stock, and 100% of these units had vested on February 21, 2026.
To cover tax withholding obligations related to this delivery, he surrendered 21,798 shares of Calumet common stock back to the company, rather than selling them on the open market. After these transactions, Borgmann directly held 263,742 shares of Calumet common stock.
Calumet, Inc. filed its Form 10-K describing its 2025 operations as a diversified producer of specialty petroleum products and renewable fuels with four segments: Specialty Products and Solutions, Performance Brands, Montana/Renewables, and Corporate.
Consolidated 2025 sales were $4.1 billion, with Specialty Products and Solutions contributing $2.63 billion, Montana/Renewables $1.19 billion, and Performance Brands $311 million. Renewable fuels revenue rose to $783.8 million and total Montana/Renewables sales increased to 28.8% of company revenue.
The company completed a corporate conversion from a master limited partnership to a C‑corporation in 2024 and reported 86.8 million common shares outstanding as of February 27, 2026. In 2025, it sold the industrial portion of its Royal Purple business for $110 million, recognizing a $55.8 million gain, while retaining the consumer Royal Purple brand.